WILMINGTON, NC (WECT) - Breast cancer patients who are considered low risk for a recurrence of the disease may not need chemotherapy.
A clinical trial was conducted at New Hanover Regional Medical Center’s Zimmer Cancer Center.
Women with early stage breast cancer were given hormonal therapy with chemotherapy while others just received the hormonal therapy.
The study compared the two groups of patients.
"It showed that women who were randomized and did hormonal therapy did just as well as those who had hormonal therapy and chemotherapy,” said Lynette McFayden, director of clinical research at the Zimmer Cancer Center.
McFayden says that’s good news for a breast cancer patient’s overall well-being.
“If they don’t need chemotherapy, they have less toxicities and better quality of life," McFayden said.
The Zimmer Cancer Center conducts clinical trials regularly. Patients interested in participating in a clinical trial can ask their physicians to refer them to the Zimmer Cancer Center.
Patients can also click here for more information on how to participate in a clinical trial and put research in the search bar.